(Q37836534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

neoadjuvant chemotherapy

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Peter Choong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Peter Choong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2

Claudia Di Bella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Louie L Gaston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John Slavin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

6 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1007-1015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00256-011-1096-4

21 January 2020

exact match

0 references

cites work

Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Evaluation of chemotherapy response in osteosarcoma with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1096-4

FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases

21 January 2018

1 reference

12 December 2020

Prognostic factors in osteosarcoma: a critical review.

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging

1 reference

12 December 2020

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

1 reference

12 December 2020

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

1 reference

12 December 2020

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

1 reference

12 December 2020

Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma

1 reference

12 December 2020

Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.

1 reference

12 December 2020

Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma

1 reference

12 December 2020

Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma

1 reference

12 December 2020

Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

1 reference

12 December 2020

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.

1 reference

12 December 2020

Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor

1 reference

12 December 2020

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

1 reference

12 December 2020

10.1007/S00256-011-1096-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21298431%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference